Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

James D. Lewis*, Gary R. Lichtenstein, Julius J. Deren, Bruce E. Sands, Stephen B. Hanauer, Jeffrey A. Katz, Bret Lashner, Daniel H. Present, Shaokun Chuai, Jonas H. Ellenberg, Lisa Nessel, Gary D. Wu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

176 Scopus citations

Fingerprint

Dive into the research topics of 'Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences